Pharmacokinetic Profile of Efavirenz in Dried Blood Spot (DBS) Samples. Comparison of Manual and Automated Extraction with the CAMAG DBS-MS Device
14 Jul 2014

Efavirenz (EFV) is a non-nucleoside reverse transcriptase inhibitor for the treatment of human HIV type 1 infection. Monitoring of EFV concentrations in DBS samples would facilitate outpatient management. This poster describes a study to test the feasibility of analyzing EFV in DBS samples using the automated CAMAG DBSMS extraction device.

Show    per page
1 of 1     Page  1 Next 
Fast UHPLC-MS/MS Method to Simultaneously Quantify Erlotinib, OSI-420, Sunitinib, SU-12662, and Pazopanib in Dried Blood Spots (DBS) dried blood spots14 Jul 2014Read
Smartpage® Summary10 Jul 2014Read
Road Map for mHealth Innovation healthcare IT systems10 Jul 2014Read
Rose Medical Center Case Study - Pneumatic Tube Installation specimen transport10 Jul 2014Read
CASE STUDY: North East Pathology Network - Sunquest ICE OpenNet healthcare IT systems9 Jul 2014Read
CASE STUDY: Royal Liverpool and Broadgreen University Hospitals NHS Trust - Sunquest ICE healthcare IT systems9 Jul 2014Read
Structured Data: Essential for Healthcare Analytics & Interoperability healthcare IT systems, software19 May 2014Read
The Value of the Laboratory in the New Healthcare Model healthcare IT systems, data analysis, software19 May 2014Read
Solutions for Efficient Sample Management and Biobanking sample handling, sample storage7 May 2014Read
DX Group Derby Hospital Case Study specimen delivery2 Oct 2013Read

Popular tags in SelectScience